Abstracts tagged "Activity score"

Abstract Number: 700 • 2015 ACR/ARHP Annual Meeting
Problems of Untranslatability: Example of Turkish Version of Basdai
Pamir Atagunduz¹, Elmar Mammadov², Ina Dervishi², Metin Beyatlı², Kubra Nur Salcı³, Nafisa Auwal Abdulhamid⁴, Gulsen Ozen⁵, Ali Ugur Unal¹, Zeynep Erturk¹, Nevsun Inanc⁵ and Haner Direskeneli⁵, ¹Rheumatology, Marmara University School of Medicine, Istanbul, Turkey, ²None, Marmara University School of Medicine, Istanbul, Turkey, ³Marmara University School of Medicine, istanbul, Turkey, ⁴Marmara University School of Medicine, Istanbul, Turkey, ⁵Department of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey
Background/Purpose: Translators of self-report forms commonly encounter problems related to untranslatability, a term used to describe words that cannot be meaningfully translated from one language…
Abstract Number: 716 • 2015 ACR/ARHP Annual Meeting
Urinary Proteomics Identifies Three Novel Biomarkers for Lupus Nephritis Activity: Retinol Binding Protein, Alpha-1-Antichymotrysin and Haptoglobin
Amita Aggarwal¹, Sudhir sinha², Ranjan Gupta³, Liza Rajasekhar⁴, Akhilesh Yadav³, Ramnath Misra¹ and Virsingh Negi⁵, ¹Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, ²Department of Biochemistry, CSIR-central drug research institute, Lucknow, India, ³Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, ⁴Department of Rheumatology, Nizam Institute of Medical Sciences, Hyderabad, India, ⁵Department of Clinical Immunology, JIPMER, Puducherry, India
Background/Purpose: Urinary biomarkers have a potential for identification, follow-up and assessment of response to treatment in patients with lupus nephritis. Urinary proteomics can help in…
Abstract Number: 745 • 2015 ACR/ARHP Annual Meeting
Changes in Serum Albumin Levels Correlate Highly with Severity and Activity of SLE
Bao Nguyen¹, Dawn Piarulli², Jennifer Johnson³ and David Horwitz^1,4, ¹Medicine, Keck School of Medicine of USC, Los Angeles, CA, ²Internal Medicine, Division of Rheumatology, Keck School of Medicine of USC, Los Angeles, CA, ³Medicine, Keck School of Medicine of USC, Los Angeles,, CA, ⁴Medicine-Rheumatology-Immun, Keck School of Medicine of USC, Los Angeles, CA
Background/Purpose: When a complex patient with long term lupus is seen for the first time, there is a need for a readily and commonly available…
Abstract Number: 753 • 2015 ACR/ARHP Annual Meeting
Serum Levels of Tenascin-C Discriminate Patients with Active SLE from Inactive Patients and Healthy Controls, and Predict the Need to Escalate Immunosuppressive Therapy
Jakub Zavada¹, Michal Uher², Radka Svobodova³, Marta Olejarova¹, Marketa Husakova³, Hana Ciferska³, Hana Hulejova⁴, Ladislav Senolt³ and Jiri Vencovsky³, ¹Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, ²Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic, ³Institute of Rheumatology, Prague, Czech Republic, ⁴Institute of Rheumatology and Department of Rheumatology, Prague, Czech Republic
Background/Purpose: The aim of this study was to examine whether circulating levels of the pro-inflammatory glycoprotein tenascin-C (TSC) are useful as an activity-specific or predictive…
Abstract Number: 2117 • 2014 ACR/ARHP Annual Meeting
Association Between Depression and High Utilization of Emergency Department in Patients with Systemic Lupus Erythematosus from the Southeastern United States: The Goal Cohort
Alfredo Aguirre¹, S. Sam Lim², Gaobin Bao³, Charles T. Molta⁴, Hong Kan⁵ and Cristina Drenkard⁶, ¹Department of Rheumatology, Emory University, Atlanta, GA, ²Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, ³Medicine, Emory University, Atlanta, GA, ⁴GlaxoSmithKline, King of Prussia, PA, ⁵5 Moore Dr, GSK, Durham, NC, ⁶Medicine, Div Rheumatology, Emory University, Atlanta, GA
Background/Purpose . Frequent visitors of the emergency department (ED) among the general population share several demographic, health system and disease characteristics, including older age, poverty,…
Abstract Number: 1777 • 2014 ACR/ARHP Annual Meeting
Staphylococcus Aureus Nasal Carriage and Relapses, Bvas, ANCA-Positivity and Cotrimoxazole Use in ANCA-Associated Vasculitis
Boun Kim Tan¹, Yoann Crabol¹, Jason Tasse^2,3, Frederic Laurent^2,3, Xavier Puechal^4,5, Christine Vinter⁶ and Loïc Guillevin^1,5, ¹Internal Medicine, Hôpital Cochin, University Paris V Descartes, Paris, France, ²Laboratoire de Bactériologie de l'hôpital de la Croix-Rousse, National Reference Centre for Staphylococci, Lyon, France, ³INSERM U1111, CNRS UMR5308, International Centre for Research in Infectious Diseases, Lyon, France, ⁴Internal Medicine, Hôpital Cochin, Paris, France, ⁵French Vasculitis Study Group (FVSG), Paris, France, ⁶Internal Medecine, Hôpital Cochin, Paris, France
Background/Purpose Staphylococcus aureus (SA) nasal carriage has been reported to be more frequent and associated with persistent ANCA-positivity and relapse in patients with granulomatosis with…
Abstract Number: 1689 • 2014 ACR/ARHP Annual Meeting
Microhaemorrages and Giant Capillaries in Nailfold Videocapillariscopies Are Able to Accurately Predict Disease Activity Level in Systemic Sclerosis
Domenico Sambataro¹, Nicoletta Del Papa¹, Gianluca Sambataro², Wanda Maglione², Eleonora Zaccara² and Claudio Vitali³, ¹Rheumatology Unit, Istituto G.Pini, Milan, Italy, ²U.O.C. Day Hospital Reumatologia, Osp. G. Pini, Milano, Italy, ³Sezione Reumatologia, Istituto San Giuseppe, Lecco, Italy
Background/Purpose Systemic Sclerosis (SSc) is a connective tissue disease characterized by Raynaud’s phenomenon, skin fibrosis and involvement of internal organs such as lung, heart, bowel,…
Abstract Number: 1632 • 2014 ACR/ARHP Annual Meeting
Is Liopxin A4 a Biomarker for Systemic Lupus Erythematosus?
Manal Sedky Abdou¹, Dina Effat², Lamiaa Mansour³, Mona mohsen Abdul Salam³ and Noha abd El Baky⁴, ¹rheumatology and rehabilitation kasr el aini hospital, faculty of medicin, cairo university, cairo, Egypt, ²rheumatology and rehabilitation, faculty of medicin, cairo university, giza, Egypt, ³clinical and chemical pathology, faculty of medicin, cairo university, cairo, Egypt, ⁴rheumatology and rehabilitation, faculty of medicin, cairo university, cairo, Egypt
Background/Purpose : Systemic lupus erythematosus (SLE) is characterized by autoantibody production and immune complex deposition which trigger both a local and systemic inflammatory response. The…
Abstract Number: 879 • 2014 ACR/ARHP Annual Meeting
Efficacy of Autologous Hematopoietic Stem Cell Transplantation in Rapidly Progressive Systemic Sclerosis: Prolonged Remission of Disease Activity in a Long-Term Follow up
Eleonora Zaccara¹, Domenico Sambataro², Wanda Maglione¹, Gianluca Sambataro¹, Francesco Onida³, Claudio Annaloro³, Giorgia Saporiti³, Elena Tagliaferri³, Agostino Cortelezzi³, Rosaria Giordano⁴, Claudio Vitali⁵ and Nicoletta Del Papa², ¹U.O.C. Day Hospital Reumatologia, Osp. G. Pini, Milano, Italy, ²Rheumatology Unit, Istituto G.Pini, Milan, Italy, ³Hematology-BMT Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico-University of Milan, Milano, Italy, ⁴Franco Calori Cell Factory, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico-University of Milan, Milano, Italy, ⁵Sezione Reumatologia, Istituto San Giuseppe, Lecco, Italy
Background/Purpose In the recent years, autologous haematopoietic stem cell transplantation (AHSCT) has been shown to represent an effective therapeutic option for patients (pts) suffering from…
Abstract Number: 74 • 2014 ACR/ARHP Annual Meeting
Influence of the Polymorphism IL1ß (-511 A/C) and IL6 (- 174 G/C) on the Activity, Radiographic Damage and Clinical Forms of Patients with Psoriatic Arthritis (PSA)
Tatiana Carranco¹, Noelia Cubino², Clara Cieza-Borrela³, Ismael Calero³, Maria Dolores Sanchez³, C. Hidalgo-Calleja⁴, Alba Quesada³, Andres Plata³, Agustin Diaz Alvarez³, Ricardo Usategui⁵, Rogelio Gonzalez⁵, C.a. Montilla-Morales⁴ and J. Del Pino-Montes⁴, ¹Reumathology, HOSPITAL CLINICO UNIVERSITARIO DE SALAMANCA, SALAMANCA, Spain, ²INTERNAL MEDICINE, HOSPITAL CLINICO UNIVERSITARIO DE SALAMANCA, SALAMANCA, Spain, ³HOSPITAL CLINICO UNIVERSITARIO DE SALAMANCA, SALAMANCA, Spain, ⁴University of Salamanca Hospital, Salamanca, Spain, ⁵IBSAL, SALAMANCA, Spain
Background/Purpose: PSA is a chronic inflammatory disease associated to psoriasis which affects the joints, vertebrae and enthesis. Interleukin-1 is an inflammatory cytokine. A higher expression…
Abstract Number: 2475 • 2013 ACR/ARHP Annual Meeting
Relationship Between Extra-Articular Manifestations and Disease Activity In Patients Diagnosed With New-Onset Spondyloarthropathy In a Cohort In Spain
César Antonio Egües Dubuc¹, Maria Martin Martinez², Joaquin Belzunegui Otano¹, Miren Uriarte Ecenarro¹, Juan Mulero³, Eugenio de Miguel⁴, Santiago Muñoz⁵, Pedro Zarco⁶, Eduardo Collantes⁷, Sabina Perez Vicente² and Milena Gobbo², ¹Rheumatology, Donostia University Hospital, San Sebastián, Spain, ²Research Unit, Spanish Society of Rheumatology., Madrid, Spain, ³Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Madrid), Spain, ⁴Rheumatology, University Hospital La Paz - IdiPaz, Madrid, Spain, ⁵Rheumatology, Hospital Infanta Sofia, Madrid, Spain, ⁶Rheumatology Service, Fundación Hospital Alcorcon, Alcorcon, Madrid, Spain, ⁷Rheumatology, Hospital Reina Sofia, Cordoba, Spain
Background/Purpose : The Spondyloarthropathy (SpA) that affect in many aspects of life of the patients, either for their musculoskeletal or extra-articular manifestations (EAM). EAM vary…
Abstract Number: 2395 • 2013 ACR/ARHP Annual Meeting
Plasma Short-Talin Is a New Rheumatoid Arthritis Monitoring Biomarker Independent Of The Inflammatory Markers
Kensei Tsuzaka, Masako Takao and Jiro Nishida, Dept of Internal Medicine, Ichikawa General Hospital,TDC, Ichikawa, Chiba, Japan
Methods: ). Sixteen (31.4 %) of these 51 patients were untreated, and 18 patients (35.3%) were treated with biologics DMARD at the time of collecting…
Abstract Number: 2289 • 2013 ACR/ARHP Annual Meeting
Correlation Of Anti-Citrullinated Protein and Anti-Carp Antibodies With Disease Duration and Activity In Rheumatoid Arthritis
Michael Mahler¹, Gabriella Lakos¹, Tyler Webb¹, Alvin Yee¹, Leendert A. Trouw² and Pier-Luigi Meroni³, ¹Research, INOVA Diagnostics, San Diego, CA, ²Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ³Int Medicine, University of Milan, Milano, Italy
Background/Purpose: Anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF) are important serological markers in the diagnosis of rheumatoid arthritis (RA) and are part of the…
Abstract Number: 1669 • 2013 ACR/ARHP Annual Meeting
The Birmingham Vasculitis Activity Score As a Measure Of Disease Activity In Patients With Giant Cell Arteritis
Tanaz A. Kermani¹, David Cuthbertson², Simon Carette³, Gary S. Hoffman⁴, Nader A. Khalidi⁵, Curry L. Koening⁶, Carol A. Langford⁷, Kathleen McKinnon-Maksimowicz⁸, Carol McAlear⁹, Paul A. Monach¹⁰, Philip Seo¹¹, Kenneth J. Warrington¹², Steven R. Ytterberg¹³, Peter A Merkel¹⁴ and Eric L. Matteson¹⁵, ¹Rheumatology, University of California Los Angeles, Los Angeles, CA, ²Department of Biostatistics, University of South Florida, Tampa, FL, ³Division of Rheumatology, University of Toronto, Toronto, ON, Canada, ⁴Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Cleveland, OH, ⁵Internal Medicine/Rheumatology, McMaster University, Hamilton, ON, Canada, ⁶Internal Medicine, Salt Lake City Veterans Administration, Salt Lake City, UT, ⁷Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, OH, ⁸Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, ⁹University of Pennsylvania, Philadelphia, PA, ¹⁰Rheumatology, Boston University, Boston, MA, ¹¹Rheumatology Division, Johns Hopkins Vasculitis Center, Johns Hopkins University, Baltimore, MD, ¹²Division of Rheumatology, Mayo Clinic, Rochester, MN, ¹³Rheumatology Division, Mayo Clinic, Rochester, MN, ¹⁴Division of Rheumatology, University of Pennsylvania and VA Medical Center, Philadelphia, PA, ¹⁵Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose: To evaluate the performance of the Birmingham Vasculitis Activity Score (BVAS), a validated tool for assessment of vasculitis disease activity, in a cohort…
Abstract Number: 1530 • 2013 ACR/ARHP Annual Meeting
Vitamin D Deficiency Is Associated With a More Active and Severe Disease In Early Axial Spondyloarthritis: Data From The DESIR Cohort
Ihsane Hmamouchi¹, Simon Paternotte², Didier Borderie³ and Maxime Dougados⁴, ¹Biostatistics, Epidemiology LBRCE, Mohamed V Souissi University, Rabat, Morocco, ²Rheumatology Department, Paris- Descartes University, Cochin hospital, Paris, France, ³Laboratoire de Biochimie, Hopital Cochin, Paris Descartes University, Pris, France, ⁴Rheumatology B Department, Paris-Descartes University, APHP, Cochin Hospital, Paris, France
Background/Purpose: Objectives a) to describe the vitamin D status b) to assess the relationship between vitamin D status and disease activity/severity and c) to estimate…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].